CIK: 0001595851 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 11, 2021
Total Value: $364M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| XBI | SPDR SER TR | 300,000 | $40.62M | 11.2% | $135.40 | — | — | Call | 78464A870 |
| — | RAPT THERAPEUTICS INC | 570,000 | $18.12M | 5.0% | $31.79 | $31.79 | — | COM | 75382E109 |
| ASND | ASCENDIS PHARMA A/S | 135,000 | $17.76M | 4.9% | $131.55 | $130.02 | — | SPONSORED ADR | 04351P101 |
| FATE | FATE THERAPEUTICS INC | 185,000 | $16.06M | 4.4% | $86.79 * | $32.72 | +146.3% | COM | 31189P102 |
| XENE | XENON PHARMACEUTICALS INC | 850,000 | $15.83M | 4.4% | $18.62 | $13.60 | +35.5% | COM | 98420N105 |
| ARVN | ARVINAS INC | 205,000 | $15.79M | 4.3% | $77.00 * | $28.07 | +147.3% | COM | 04335A105 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 875,000 | $15.02M | 4.1% | $17.17 * | $18.21 | +0.6% | COM | 87164F105 |
| KURA | KURA ONCOLOGY INC | 700,000 | $14.6M | 4.0% | $20.85 * | $28.09 | -11.6% | COM | 50127T109 |
| COGT | COGENT BIOSCIENCES INC | 1,600,000 | $12.98M | 3.6% | $8.11 * | $10.56 | -20.0% | COM | 19240Q201 |
| — | TRILLIUM THERAPEUTICS INC | 1,250,000 | $12.13M | 3.3% | $9.70 | $7.71 | — | COM NEW | 89620X506 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 450,000 | $11.71M | 3.2% | $26.02 | $24.73 | +5.1% | COM | 462260100 |
| BIIB | BIOGEN INC | 32,500 | $11.25M | 3.1% | $346.28 * | $283.10 | +7.0% | COM | 09062X103 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 285,000 | $9.53M | 2.6% | $33.44 * | $23.51 | +16.7% | COM NEW | 15117B202 |
| — | MIRATI THERAPEUTICS INC | 50,000 | $8.077M | 2.2% | $161.54 | $82.63 | — | COM | 60468T105 |
| ALLO | ALLOGENE THERAPEUTICS INC | 275,000 | $7.172M | 2.0% | $26.08 * | $28.52 | 0.0% | COM | 019770106 |
| TGTX | TG THERAPEUTICS INC | 180,000 | $6.982M | 1.9% | $38.79 | $18.29 | +114.7% | COM | 88322Q108 |
| ALDX | ALDEYRA THERAPEUTICS INC | 600,000 | $6.798M | 1.9% | $11.33 * | $4.21 | +185.3% | COM | 01438T106 |
| — | VERONA PHARMA PLC | 1,000,000 | $6.54M | 1.8% | $6.54 | $6.53 | — | SPONSORED ADS | 925050106 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 350,000 | $6.402M | 1.8% | $18.29 * | $18.49 | -7.4% | COM | 92790C104 |
| — | SATSUMA PHARMACEUTICALS INC | 904,225 | $6.375M | 1.8% | $7.05 | $10.24 | — | COM | 80405P107 |
| — | VISTAGEN THERAPEUTICS INC | 2,000,000 | $6.3M | 1.7% | $3.15 | $2.02 | — | COM NEW | 92840H202 |
| — | MERSANA THERAPEUTICS INC | 450,000 | $6.111M | 1.7% | $13.58 | $10.98 | — | COM | 59045L106 |
| BCYC | BICYCLE THERAPEUTICS PLC | 200,000 | $6.072M | 1.7% | $30.36 | $30.00 | — | SPONSORED ADS | 088786108 |
| — | ESSA PHARMA INC | 207,500 | $5.928M | 1.6% | $28.57 | $28.98 | — | COM NEW | 29668H708 |
| RCKT | ROCKET PHARMACEUTICALS INC | 125,000 | $5.536M | 1.5% | $44.29 | $19.92 | +118.0% | COM | 77313F106 |
| MLTX | HELIX ACQUISITION CORP | 500,000 | $5.175M | 1.4% | $10.35 | $11.37 | — | COM CL A | G4444C102 |
| GLPG | GALAPAGOS NV | 75,000 | $5.167M | 1.4% | $68.89 | $68.89 | — | SPON ADR | 36315X101 |
| TARS | TARSUS PHARMACEUTICALS INC | 170,000 | $4.927M | 1.4% | $28.98 * | $31.23 | 0.0% | COM | 87650L103 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 243,309 | $4.586M | 1.3% | $18.85 * | $17.57 | 0.0% | COM | 22663K107 |
| — | IVERIC BIO INC | 725,000 | $4.575M | 1.3% | $6.31 | $7.44 | — | COM | 46583P102 |
| ACRS | ACLARIS THERAPEUTICS INC | 250,000 | $4.39M | 1.2% | $17.56 * | $4.22 | +438.5% | COM | 00461U105 |
| — | CATALYST BIOSCIENCES INC | 1,000,000 | $4.33M | 1.2% | $4.33 | $5.04 | — | COM NEW | 14888D208 |
| — | CTI BIOPHARMA CORP | 1,600,000 | $4M | 1.1% | $2.50 | $2.84 | — | COM | 12648L601 |
| — | SIERRA ONCOLOGY INC | 200,000 | $3.894M | 1.1% | $19.47 | $16.03 | — | COM NEW | 82640U404 |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | 125,000 | $3.529M | 1.0% | $28.23 * | $30.00 | 0.0% | COM | 413197104 |
| PCVX | VAXCYTE INC | 145,000 | $3.264M | 0.9% | $22.51 * | $20.47 | 0.0% | COM | 92243G108 |
| IMUX | IMMUNIC INC | 265,000 | $3.249M | 0.9% | $12.26 * | $16.38 | -15.5% | COM | 4525EP101 |
| — | KADMON HLDGS INC | 800,000 | $3.096M | 0.9% | $3.87 | $3.88 | — | COM | 48283N106 |
| FOLD | AMICUS THERAPEUTICS INC | 265,000 | $2.555M | 0.7% | $9.64 | $14.57 | -33.0% | COM | 03152W109 |
| IMVT | IMMUNOVANT INC | 200,000 | $2.114M | 0.6% | $10.57 * | $11.17 | +25.0% | Call | 45258J102 |
| — | CURIS INC | 247,124 | $1.994M | 0.5% | $8.07 | $8.19 | — | COM NEW | 231269200 |
| — | CEREVEL THERAPEUTICS HLDNG I | 75,000 | $1.922M | 0.5% | $25.63 | $25.63 | — | COM | 15678U128 |
| — | CHIMERIX INC | 200,000 | $1.6M | 0.4% | $8.00 | $9.64 | — | COM | 16934W106 |
| — | MERUS N V | 75,000 | $1.58M | 0.4% | $21.07 | $21.07 | — | COM | N5749R100 |
| — | ELEVATION ONCOLOGY INC | 100,000 | $1.357M | 0.4% | $13.57 | $13.57 | — | COM | 28623U101 |
| — | PROVENTION BIO INC | 150,000 | $1.265M | 0.3% | $8.43 | $8.43 | — | Put | 74374N102 |
| — | CASI PHARMACEUTICALS INC | 650,000 | $1.008M | 0.3% | $1.55 | $2.40 | — | COM | 14757U109 |
| — | OTONOMY INC | 450,000 | $1.004M | 0.3% | $2.23 | $4.29 | — | COM | 68906L105 |
| LRMR | LARIMAR THERAPEUTICS INC | 100,000 | $982K | 0.3% | $9.82 * | $11.30 | 0.0% | COM | 517125100 |
| MRNA | MODERNA INC | 4,000 | $940K | 0.3% | $235.00 * | $178.71 | 0.0% | COM | 60770K107 |
| — | PROVENTION BIO INC | 100,000 | $843K | 0.2% | $8.43 | $8.43 | — | COM | 74374N102 |
| — | CODEX DNA INC | 35,000 | $770K | 0.2% | $22.00 | $22.00 | — | COM | 192003101 |